InvestorsHub Logo
Followers 33
Posts 5288
Boards Moderated 0
Alias Born 01/23/2019

Re: None

Friday, 09/11/2020 3:48:23 PM

Friday, September 11, 2020 3:48:23 PM

Post# of 425821
Here you go! it was sent on July 14, 2020 #286039
jwjones62

jwjones62 Tuesday, 07/14/20 03:47:03 PM
Re: None 0
Post #
286039
of 298471
I sent the following email to John Thero and Elizabeth..

Good afternoon John,

I am writing as a shareholder and a big believer in Vascepa and its enormous potential to help so many people. I have grown increasingly frustrated with the performance in the execution of the commercialization of Vascepa by Amarin Management. This has been highlighted by the impractical Nevada court filing and allowing the court case to proceed without setting with H&R. This decision may be a fatal blow to AMRN and its shareholders. We are all essentially holding our breath and praying that Mr. Singer can win the appeal. It should never have come to this.

I have 2 areas of concern that I would like addressed.

1.) After suffering the enormous judicial setback which resulted in crippling the commercialization efforts and destroying shareholder value in Amarin stock, please explain how Amarin chose to file another patent infringement suit in NEVADA of all places? It also appears the suit was also assigned to Judge Miranda Du. Please share some insight as to how the Nevada courts could once again be chosen to file a secondr court case, since the first selection devastated your loyal shareholders. Don't you have a fiduciary responsibility to preserve and increase shareholder value?

2.) Why haven't the voting results or any update from the annual shareholder meeting been publicized?

I am eagerly awaiting your response.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News